Fight for Your Rights in the Tepezza Lawsuit: How Half-Dose Therapy Can Help Resolve Teprotumumab-Induced Hearing Loss

The newly released Stanford University study titled “Reduction of Teprotumumab-Induced Hearing Loss With Comparable Efficacy Using Half-Dose Therapy” provides valuable...